COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

“Increasing R&D investments in pharmaceutical companies is a major factor driving the growth of the glycomics market.”
The global glycomics market is projected to reach USD 2.0 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 13.8% during the forecast period. The growth of this market is majorly driven by the increasing R&D expenditure and funding for proteomics and glycomics research, growth of the proteomics market, and technological advancements in glycomics instrumentation. However, the high cost of tools is expected to be the major challenge for the growth of the global glycomics market during the forecast period.

“Academic research institutes segment accounted for the largest share of the glycomics market, by end-user, in 2019.”
Based on end-user, the glycomics market is segmented into academic research institutes, pharmaceutical and biotechnology companies, and clinical laboratories. Academic research institutes are estimated to be the largest end-users of glycomics products in 2020. This end-user segment is also projected to grow at the highest CAGR during the forecast period. The large share and high growth of this end-user segment can be attributed to factors such as the increasing number of research activities on drug discovery, rising funding for glycomics research, and increasing number of collaborations for developing carbohydrate-based drugs.

“Enzymes segment to register the highest growth in the glycomics market during the forecast period.”
Based on the products, the glycomics market is categorized into five product segments, namely, enzymes, instruments, kits, carbohydrates, and reagents & chemicals. The enzymes segment is expected to dominate the market in 2020 and is projected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the consumable nature of enzymes and their wide applications in a variety of R&D and drug discovery procedures.

“North America will continue to dominate the glycomics market during the forecast period.”
Geographically, the global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). In 2020, North America is expected to dominate the global glycomics market. This is mainly due to increasing funding for research on glycomics, rising R&D investments for drug discovery & development, and the presence of key players in the region.

The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24%
By Designation: C-level - 30%, D-level - 34%, and Others - 36%
By Region: North America - 50%, Europe - 32%, Asia Pacific - 10%, and Rest of the World - 8%

List of companies profiled in the report

  • Merck KGaA (Germany)
  • Agilent Technologies (US)
  • Thermo Fisher Scientific (US)
  • New England Biolabs (US)
  • Shimadzu Corporation (Japan)
  • Takara Bio (Japan)
  • S-BIO (a subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • Waters Corporation (US)
  • Asparia Glycomics S.L. (Spain)
  • Bio-Techne (US)
  • Bruker Corporation (US)
  • Danaher Corporation (US)
  • RayBiotech (US)
  • Z Biotech (US)
  • Chemily Glycoscience (US)
  • Dextra Laboratories (UK)
  • Lectenz Bio (US)
  • Ludger Ltd. (UK)
  • Valiant Co., Ltd (China)
  • Sanyo Fine Co., Ltd. (Japan)

Research Coverage:
This report provides a detailed picture of the global glycomics market. It aims at estimating the size and future growth potential of the market across different segments (by product, application, end-user, and region). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

  • This report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall glycomics market and its subsegments.
  • It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies.
  • Also, this report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, and opportunities.